Skip to main content

MYOV Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Myovant Sciences Ltd. News

Are These Three Biotech Stocks on Your Radar?

The persistent gulf between big cap growth stocks and downtrodden secondary stocks like biotechs is showing signs of narrowing.

Insiders Are Buying Biotech Stocks Again

Things may be looking up for biotech stocks, says Real Money's Bret Jensen.

5 Top Stock Gainers for Monday: Myovant Sciences, Yelp

Myovant Services, Yelp, Greenpro Capital, Live Oak Acquisition and Gevo.

Stocks Close at Records as Trump Signs Relief and Funding Package

Stocks close at record highs as President Trump signs a combined $2.3 trillion coronavirus relief and government funding package.

Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug

Myovant and Pfizer will develop Orgovyx for advanced prostate cancer and, if approved, a combination tablet that includes the drug in women’s health.

Breaking News

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Roe v. Wade: Google Makes a Major Decision to Protect Privacy

Google will delete a person's location history for going to an abortion clinic.

Elon Musk Drops The Curtain On His Natures

The billionaire and CEO of Tesla remains an enigma despite its omnipresence on social media.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.